Geir Åge Løset
Directeur Général chez Nextera AS
Postes actifs de Geir Åge Løset
Sociétés | Poste | Début | Fin |
---|---|---|---|
Nextera AS
Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Directeur Général | - | - |
Fondateur | 01/01/2009 | - | |
Directeur Technique/Scientifique/R&D | 01/01/2009 | - |
Historique de carrière de Geir Åge Løset
Anciens postes connus de Geir Åge Løset
Sociétés | Poste | Début | Fin |
---|---|---|---|
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - | - |
University of Oslo | Corporate Officer/Principal | - | - |
Formation de Geir Åge Løset
University of Oslo | Doctorate Degree |
Statistiques
Internationale
Norvège | 3 |
Danemark | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Commercial Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Nextera AS
Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Commercial Services |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bourse
- Insiders
- Geir Åge Løset
- Expérience